HIV/AIDS

HIV virus

A “public” target for HIV

Common sequences of antibodies against HIV may be key to developing a successful vaccine strategy for the virus.

HIV virus

AIDS-defining events increase mortality risk: study

When they occur among people living with HIV, certain cancers and opportunistic infections are considered by health authorities as AIDS-defining events, or ADEs.

HIV outreach and return to care

When chronic disease patients let their care lapse and fail to show for clinic appointments, it may behoove clinics to reach out and encourage a return to care.

VIGH receives federal grants to fight kidney disease

Researchers in the Vanderbilt Institute for Global Health (VIGH) have received two new grants from the National Institutes of Health (NIH) aimed at reducing the risk of kidney disease in HIV-infected adults and improving the treatment of epilepsy in children in Nigeria.

Major international study testing therapy to prevent spread of HIV

Nine more volunteers are needed to complete a study at Vanderbilt University Medical Center (VUMC) that could lead to a way to prevent the spread of HIV (human immunodeficiency virus).

Combination therapy PrEP offers effective way to prevent HIV infection

Rates of new HIV infections in the United States are declining — except among men who have sex with men. Rates are particularly high among African-American and Hispanic men and especially in the South.

1 2 3 4 5 6 7